First in Korea to Obtain MFDS Approval
Launch of Personal Urine and Saliva-Based Test Kits

HealthyMed, a company specializing in in vitro diagnostic medical devices, is launching a personal drug self-test kit capable of simultaneously detecting up to 19 types of narcotics.


(from left) K-rapid check urine cup-type drug test kit, urine panel-type, saliva stick-type, urine strip-type drug test kits. HealthyMed

(from left) K-rapid check urine cup-type drug test kit, urine panel-type, saliva stick-type, urine strip-type drug test kits. HealthyMed

View original image

On June 16, HealthyMed announced the release of the "K-Rapid Check" drug test kit, the first in Korea to be approved by the Ministry of Food and Drug Safety for simultaneous urine-based detection of 19 different narcotic substances.


As drug-related crimes are on the rise and the range of detectable substances is diversifying, demand for prevention and confirmation at the individual level is also increasing. In particular, the circulation of not only methamphetamine but also cocaine, ketamine, MDMA (ecstasy), synthetic cannabis, fentanyl, and various new types of drugs has highlighted the need for comprehensive multi-substance testing.

HealthyMed explained that, in response to these market trends, it has developed a product that allows for the simultaneous detection of multiple narcotics without specifying particular substances in advance.


The "K-Rapid Check" drug test kit is based on urine analysis and offers customizable panels ranging from 5 to 19 types of substances depending on the intended use. The kit is available in various formats, including cup-type, panel-type, and strip-type for urine, as well as a stick-type product for saliva (oral fluid) testing.


The company emphasized that, since drug testing has traditionally been focused on public institutions and medical facilities, it has concentrated on developing a product suitable for personal use. This kit enables a simple preliminary screening test after sample collection without any special equipment.


HealthyMed has adopted lower cut-off criteria compared to industry standards, aiming to detect even trace amounts of substances. The company reported that each product demonstrated an average accuracy of over 95% in performance evaluations. It also explained that certain substances can still be detected after a specific period, depending on how long they remain in the body.



Choi Jungyun, CEO of HealthyMed, stated, "Addressing drug-related issues is becoming increasingly focused on prevention and early detection, not just enforcement. We will continue to develop self-testing environments and related technologies and products that individuals can use in their daily lives."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing